Gerald W. McLaughlin
CIK 1495412 · Chief Executive Officer · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.82M
Companies
4
Total Filings
21
Lifetime Open-Market Net
$51.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALLR | Director | 70,000 | $1.43 | $100.1K | $0 | 3 | 2026-05-07 |
| AYTU | Director | 31,401 | $2.15 | $67.5K | $0 | 1 | 2021-04-12 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Chief Executive Officer | 0 | $1.15 | $0 | $51.2K | 9 | 2021-03-19 |
| PATH | VP, ChiefCommercial Officer | 156,651 | $10.55 | $1.65M | $0 | 3 | 2013-01-22 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.